StockWatch
·

WOCKHARDT LTD.

BSE: 532300

values in crores

Revenue & Profit Trend

in crores
RevenueExpenditureNet Profit
-112.30148.57409.43670.30Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27

Margin Trend

percentage
OPM %NPM %
-47.45-15.2616.9349.12Q3 FY25Q4 FY25Q1 FY26Q2 FY26Q3 FY26Q4 FY26Q1 FY27Q2 FY27
PeriodQ2 FY27Q1 FY27Q4 FY26Q3 FY26Q2 FY26Q1 FY26Q4 FY25Q3 FY25
INCOME
Revenue580.00+3.4%561.00+8.7%516.00+20.0%430.00+13.2%380.00-8.0%413.00+16.3%355.00+9.2%325.00
Other Income21.00-36.4%33.00-40.0%55.00+103.7%27.00-10.0%30.00+20.0%25.00+78.6%14.00+133.3%6.00
Total Income601.00+1.2%594.00+4.0%571.00+24.9%457.00+11.5%410.00-6.4%438.00+18.7%369.00+11.5%331.00
EXPENSES
Expenditure501.00+2.9%487.00+10.9%439.00+4.8%419.00+17.7%356.00-3.5%369.00+12.2%329.00-6.8%353.00
Tax0.000.000.000.000.000.000.00—
PROFIT
PBT100.00-6.5%107.00-35.9%167.00+496.4%28.00-48.1%54.00-21.7%69.00+72.5%40.00+281.8%-22.00
Net Profit100.00-6.5%107.00-35.9%167.00+496.4%28.00-48.1%54.00-21.7%69.00+72.5%40.00+281.8%-22.00
KEY METRICS
OPM %30.00%+1.84pp28.16%-9.82pp37.98%+14.03pp23.95%-5.79pp29.74%-1.98pp31.72%+1.86pp29.86%+66.17pp-36.31%
NPM %16.64%-1.37pp18.01%-11.24pp29.25%+23.12pp6.13%-7.04pp13.17%-2.58pp15.75%+4.91pp10.84%+17.49pp-6.65%
EPS6.15-7.1%6.62-35.7%10.29+494.8%1.73-46.9%3.26-23.3%4.25+72.1%2.47+276.4%-1.40

Corporate Events

Board MeetingWOCKPHARMA
2026
2Nov

Board Meeting

The meeting of the Board of Directors will be held to consid…

BSE Filing ↗
Board MeetingWOCKPHARMA
2026
10Aug

Board Meeting

The 27th Annual General Meeting will be held to transact ord…

BSE Filing ↗
Board MeetingWOCKPHARMA
2024
9Aug

Board Meeting

Consider and approve Un-Audited Financial Results (Standalon…

BSE Filing ↗
Board MeetingWOCKPHARMA
2024
28May

Board Meeting

Consider and approve Audited Financial Results and fund rais…

BSE Filing ↗
Board MeetingWOCKPHARMA
2024
26Mar

Board Meeting

Consider and approve issue price of Equity Shares

BSE Filing ↗
Board MeetingWOCKPHARMA
2024
14Feb

Board Meeting

Consider and approve Un-Audited Financial Results (Standalon…

BSE Filing ↗
Board MeetingWOCKPHARMA
2023
14Nov

Board Meeting

Consider and approve Un-Audited Financial Results (Standalon…

BSE Filing ↗
Board MeetingWOCKPHARMA
2023
14Aug

Board Meeting

Approval of Unaudited Financial Results (Standalone & Consol…

BSE Filing ↗